Font:
BL

BLISSGVS / NSE / Biotechnology & Drugs

Bliss GVS Pharma

INR 438.351.80 (-4.41%) 1D
Last updated: 2026-06-15T14:48:06.917937+00:00
Price Chart

1Y Price Trend

Open153
High462.8
Low118
Close437.85
Volume5,21,869
Change284.85
Change %186.18%

Key Information

Ticker SymbolBLISSGVS
Current Price438.35
52-Week High462.8
52-Week Low118
Market Cap4,619.81
Beta0.82
Volume5,21,869
ISININE416D01022
Day High449.9
Day Low435.55
Open441.4

Recommendations

Target High462.7

Target Low118.35

Target Mean0

Target Median0

Risk Metrics

Overall RiskHigh risk

Board Risk63.34

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

SN Kamath appointed MD, Bliss GVS Pharma Ltd - Whispers In The Corridors9 days ago
Market news

SN Kamath appointed MD, Bliss GVS Pharma Ltd Whispers In The Corridors

Anupam Rasayan launches open offer for Bliss GVS Pharma after acquiring 43.3% stake - CNBC TV1810 days ago
Market news

Anupam Rasayan launches open offer for Bliss GVS Pharma after acquiring 43.3% stake CNBC TV18

Anupam Rasayan files draft offer for Bliss GVS - scanx.trade10 days ago
Market news

Anupam Rasayan files draft offer for Bliss GVS scanx.trade

Anupam Rasayan targets 25-30% revenue recovery in FY27 following strategic Bliss GVS Pharma acquisition - MSN15 days ago
Market news

Anupam Rasayan targets 25-30% revenue recovery in FY27 following strategic Bliss GVS Pharma acquisition MSN

Anupam Rasayan to acquire up to 43% stake in Bliss GVS Pharma for around Rs 1,369 crore - MSN15 days ago
Market news

Anupam Rasayan to acquire up to 43% stake in Bliss GVS Pharma for around Rs 1,369 crore MSN

Bliss GVS Pharma Ltd hits 52-week high of ₹447 Amid WHO Approval, Strong Earnings and Acquisition Boost - India Infoline16 days ago
Market news

Bliss GVS Pharma Ltd hits 52-week high of ₹447 Amid WHO Approval, Strong Earnings and Acquisition Boost India Infoline

Bliss GVS Pharma rises on securing Inspection Closure Report from WHO - Investment Guru India16 days ago
Market news

Bliss GVS Pharma rises on securing Inspection Closure Report from WHO Investment Guru India

Here's why Bliss GVS Pharma shares have surged over 45% over the last 10 sessions - CNBC TV1816 days ago
Market news

Here's why Bliss GVS Pharma shares have surged over 45% over the last 10 sessions CNBC TV18

FAQ

Stock FAQs

What is the NSE symbol for Bliss GVS Pharma?

Bliss GVS Pharma trades on NSE with the symbol BLISSGVS. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Bliss GVS Pharma share price and chart?

You can track Bliss GVS Pharma share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Bliss GVS Pharma?

Yes. ShareKeyX displays available financial statements for Bliss GVS Pharma using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Bliss GVS Pharma?

Yes. ShareKeyX displays available historical OHLC candles for Bliss GVS Pharma across supported chart ranges such as 7D, 1M, 3M, 6M and 1Y.

What sector or industry does Bliss GVS Pharma belong to?

Bliss GVS Pharma is classified under Biotechnology & Drugs in the available company data.

Does ShareKeyX show news for Bliss GVS Pharma?

Yes. ShareKeyX shows the latest available stock news for Bliss GVS Pharma from the connected stock news source.